HIV/human T cell lymphotropic virus (HTLV) coinfection has a large range of prevalence in
the different risk groups and geographic regions of the world. Most of the HTLV-infected …

Serum specimens (n= 1899) were assayed for infections with HTLV-I, HTLV-II, and HIV-1 in
seven classified groups of normal healthy controls, children, pregnant women, prostitutes …

Serum samples from 895 HIV-1 infected individuals were tested for antibodies against HTLV-
I and HTLV-II. The overall prevalence of the co-infection was high (16.3%). Epidemiological …

BACKGROUND: Routine diagnosis of Human T Lymphotropic virus (HTLV) infection is
primarily serologically based; however the proportion of unresolved and indeterminate …

Human immunodeficiency virus (HIV) and human T‐cell lymphotropic virus (HTLV) are both
retroviruses with similar routes of transmission. A number of reports suggest variable clinical …

Objectives: To determine the seroprevalence of, and risk factors for, HTLV-I and HTLV-II
infection among HIV-infected women and women at high risk for HIV infection. Design …

A high frequency of false-negative anti-HTLV-I/II ELISA results has been reported by several
authors. To verify the possible underestimate of the prevalence of HTLV-II infection in …

Objective: To assess the prevalence of HTLV infection and its association with HIV and other
potential risk factors. Design and Setting: A cross-sectional survey and a case-control study …

Infection with human T lymphotropic virus (HTLV), although asymptomatic in most cases,
can lead to severe illnesses, such as adult T cell leukemia/lymphoma or myelopathy/tropical …

A serological survey for HTLV infection identified an AIDS patient with HTLV-I/HTLV-II dual
seroreactivity. Two further sequential blood samples were collected (samples A and B) for …